BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor-resistant BRCA-mutant ovarian cancer https://www.medrxiv.org/content/10.1101/2022.12.02.22283037
BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor-resistant BRCA-mutant ovarian cancer https://www.medrxiv.org/content/10.1101/2022.12.02.22283037